Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of hydrocortisone, vitamin C and thiamine in patients with sepsis and septic shock
2018-000196-32Phase 3Terminated
- Sponsor
- Hospital Universitari de Girona Dr. Josep Trueta
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone, ascorbic acid and thiamine in septic shock and sepsis (2 arms), sponsored by Hospital Universitari de Girona Dr. Josep Trueta. Primary endpoint: 28-day ICU mortality. Started Oct 2018; status: terminated.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on 2018-000196-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000196-32.